R&D center in Raleigh||
Share:

Cambridge Design Partnership opens state-of-the-art R&D center in Raleigh, NC, and kicks off local recruitment drive

World-leading technology and product design company Cambridge Design Partnership (CDP) today open its new, state-of-the-art R&D center in Raleigh, North Carolina. Now in its 25th year, the company has seen impressive growth over the last 12 months, securing major new clients, delivering world-changing innovation and growing headcount by more than 40%. This success, fueled by client work in the fields of drug delivery, molecular diagnostics, consumer devices, surgical robotics and more, has driven CDP to make a considerable investment in new facilities in North Carolina’s Research Triangle.

CDP has refurbished a historic building on West Morgan Street, in the heart of downtown Raleigh. Working with the existing structure and respecting the heritage of the building and neighborhood, the company is committed to growing roots in the Raleigh community and creating new, highly-skilled job opportunities.

With the new facilities operational, attention now turns to a major recruitment drive, with positions open across a range of disciplines, including mechanical, electrical and software engineering, human factors, quality, manufacturing, and industrial design. Early-stage professionals are invited to apply to a new intern program.

CDP has chosen to anchor its new R&D center and US headquarters in North Carolina’s Research Triangle due to the region’s thriving biomedical innovation sector, excellent transport links and deep pool of skilled engineers and technologists. Aki Laakso, Partner and CDP’s Director of Raleigh Operations said, “In the past, we have served a global client base from our headquarters in Cambridge, UK. We have seen a strong increase in demand from our US clients in the past ten years, with more than half our business today coming from America. Our new Raleigh facilities, with cutting-edge labs, a design studio, user observation suite, full machine shop, and pilot manufacture space, allow us to more effectively deliver world-changing innovation in the US.”

(Image, left: Hans Pflaumer, right: Aki Laakso)

Since 2019, CDP’s US operation has been led by Aki Laakso and Hans Pflaumer. Aki Laakso is an experienced mechanical engineer with a storied history that includes three years at NASA Goddard Space Flight Center and innovation across disciplines, from wearables to drug delivery devices. Hans Pflaumer has a proud track record of bringing first-of-a-kind medical devices to market and is a recognized visionary in the field of minimally invasive medical devices, with a focus on surgical robotics.

“Our new facility is a sign of the confidence we have in our US operation. The Research Triangle, with its strong culture of innovation and skilled workforce, is the right place for us,” said Aki Laakso. “We’re recruiting for a variety of exciting roles and look forward to growing right here in Raleigh.” he added.

CDP delivers end-to-end product and technology development for clients in the healthcare, consumer, and industrial equipment sectors. CDP’s work starts at the point a business decides on the need for innovation and finishes with the launch of a breakthrough new product that is customer focused and commercially effective.

Explore openings at CDP


For further information and media inquiries, please contact: media@cambridge-design.com or call +44 1223 264428


|||||
Share:

CDP completes pilot manufacture of Point of Care diagnostic readers for rapid COVID-19 testing

A team at UK product and innovation company Cambridge Design Partnership (CDP) has produced highly deployable devices for COVID-19 testing. CDP has been collaborating with diagnostics tech firm QuantuMDx to refine their Q-POC™ device and produce the first batch of readers to detect COVID-19 within approximately 30 minutes. QuantuMDx is now investing over £11 million to scale up production and introduce this rapid diagnostic solution to benefit patients and frontline health workers across the globe.

QuantuMDx is developing molecular diagnostic devices for a range of diseases and has developed and launched a highly accurate lab-based SARS-CoV-2 assay. Prior to the COVID-19 outbreak, the firm had commissioned CDP to produce prototype devices for CE marking. CDP worked through the first UK lockdown to improve the design of the reader and the first units are deployed at UK hospitals for COVID-19 testing studies.

“After beginning our partnership with QuantuMDx during 2019, we were delighted to be asked to collaborate with this innovative company once again, at a critical time. The team has been highly motivated by this crucial project and proud to contribute to the national effort,” says Dan Haworth, CDP’s Head of Diagnostics.

Colin Toombs, VP Research & Development at QuantuMDx, said: “We’ve worked in partnership with CDP since April last year, to undertake accelerated pilot manufacture of our Q-POC™ device, which is a portable DNA/RNA analyser offering rapid, sample-to-answer, molecular diagnostic testing at the point of care. The QuantuMDx and CDP teams have worked in close partnership to optimise our product development and manufacture devices to deliver testing for COVID-19. They are being released initially for research use, but we are rapidly moving towards CE-IVD of Q-POC™ for SARS-CoV-2 detection. Working together with CDP, we’ve established an ongoing partnership for the future.”

The device works by processing a swab sample, amplifying the target sequence specific to SARS-CoV-2, which causes COVID-19, and then detecting whether the virus is present. This all happens within a sealed cartridge that is controlled by the reader with minimal user involvement.

“Within approximately 30 minutes from sample collection, the device will give an accurate answer to whether the patient has COVID-19” says Dan.

These first new readers have been designed and built at CDP’s HQ in Cambridgeshire, where the company has short-run manufacture capability alongside its R&D facilities.

CDP’s team working to develop the QuantuMDx device includes mechanical and electronics engineers, software engineers, regulatory experts and manufacturing engineers.

“We worked at speed to design, build and test these important devices as quickly as possible. We are all thrilled to play our part in beating COVID-19 and we congratulate QuantuMDx on moving to mass manufacture,” added Dan.

 

For further information and media enquiries, please contact: media@cambridge-design.com or call 01223 264428

Covid Visors
Share:

CDP helps create emergency face visors for healthcare workers

In response to the national shortage of Personal Protective Equipment (PPE), Cambridge Design Partnership is working on a project to create 1,000 face visors a day

A team from Cambridge Design Partnership (CDP) is helping to manufacture protective face visors for healthcare workers during the Covid-19 outbreak.

CDP staff based at the firm’s HQ in Toft, Cambridgeshire are working pro bono on a project called NHS Visors.

“Our role is to ensure that the face visors are being made to an acceptable standard of quality and safety,” said Jonathan Wilkins, senior consultant at CDP, who is leading the team working on the project.

“We have drawn on our expertise in designing medical devices to ensure that the emergency production line is creating visors that comply with health and safety regulatory standards.”

The NHS Visors project has been set up by Warwickshire engineering and machinery development company 3P Innovation. “When we heard they were creating the visors, we were excited to help out,” said Jonathan.

The project was launched when it became clear the country was perilously short of PPE for hospitals and care homes. Initially, the project assembled visors using 3D-printed components made by hundreds of businesses and individuals with 3D printers.

When 3P scaled up its manufacturing processes to deliver larger quantities, CDP helped by navigating through the rapidly changing Covid-19 emergency quality regulations: “Compliance with regulations is needed but in a very tight time frame,” explained Jonathan.

“This is a safety critical product and is used by healthcare workers tackling Covid-19 at the frontline. Although there are emergency relaxations on legislation in place at the moment due to the desperate shortage of PPE, it is crucial that face visors sent to frontline workers are fit for purpose.”

CDP’s work for the project included developing a strategy for regulatory compliance and testing, advising on quality processes required for the manufacturing process, and assessing the ergonomics of the finished product to check it is practical and comfortable to use. “It’s our aim to ensure the visors are both effective and comply with legislation,” said Jonathan. “Indeed, the visors have recently been awarded a certificate for compliance with the European Standard for PPE eye protection.”

CDP’s help has been “hugely appreciated”, said Simon Strothers of 3P Innovation who is working on the NHS Visors project as a volunteer. “We are very grateful that our friends at CDP offered to help out, working so swiftly to make our new visors safe and legal. We have been amazed how quickly we have collectively got this project off the ground.

“We are supplying the visors free of charge wherever they are needed, taking the orders direct here at our HQ and delivering them with a team of motorbike volunteers. In some cases, healthcare staff have literally broken down in tears to receive the visors. They are life-saving pieces of kit in this current epidemic. Many care homes and NHS centres simply don’t have enough to ensure staff safety.”

The NHS Visors project initially created 4,500 visors made on 3D printers. “This is quite an achievement when you consider each one takes hours to print out on a 3D printer,” says Simon.

“Then as the severity of the shortage became clear, we appealed for help to set up higher-volume production. Mondelez International, owner of the famous Cadbury chocolate brand, agreed to step in and fund the purchase of injection moulding tools for the key visor components. We can now make injection-moulded headbands for the visors and we have also purchased a clicker press cutter to create the clear visor itself.

“At this stage, CDP’s input into ensuring that production meets the accepted safety standards was invaluable. We can now make visors in seconds rather than hours.”
The volunteers are now producing over 8,000 face visors a week. “We offer them to anyone who needs them,” said Simon. “If hospitals, care homes or other emergency healthcare workers would like some, please do get in touch.”

Staff at CDP are also working on a range of Covid-19 projects including ventilators and diagnostic devices, as well as the NHS Visors project. “We are only too pleased that the NHS Visors project asked us to help build them a better PPE product at short notice,” said Jonathan. “We are highly motivated to use our expertise in whatever way we can to help overcome the pandemic.”

For further information and media enquiries, please contact: media@cambridge-design.com or call 01223 264428